|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-4-20
|
|
pubmed:abstractText |
Inhibition of glutamatergic N-methyl-D-aspartate (NMDA) receptors following the administration of NMDA receptor antagonists results in psychotic-like behaviour. Whereas it is known that pharmacological manipulation of dopaminergic and serotonergic pathways affect this drug-induced psychosis, a role for noradrenaline has not yet been clearly defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic Uptake Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Benzylamines,
http://linkedlifedata.com/resource/pubmed/chemical/Clonidine,
http://linkedlifedata.com/resource/pubmed/chemical/DSP 4,
http://linkedlifedata.com/resource/pubmed/chemical/Desipramine,
http://linkedlifedata.com/resource/pubmed/chemical/Dizocilpine Maleate,
http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Morpholines,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Prazosin,
http://linkedlifedata.com/resource/pubmed/chemical/reboxetine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0033-3158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
154
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
177-88
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11314680-Adrenergic Agents,
pubmed-meshheading:11314680-Adrenergic Uptake Inhibitors,
pubmed-meshheading:11314680-Adrenergic alpha-Agonists,
pubmed-meshheading:11314680-Adrenergic alpha-Antagonists,
pubmed-meshheading:11314680-Animals,
pubmed-meshheading:11314680-Ataxia,
pubmed-meshheading:11314680-Benzylamines,
pubmed-meshheading:11314680-Clonidine,
pubmed-meshheading:11314680-Desipramine,
pubmed-meshheading:11314680-Dizocilpine Maleate,
pubmed-meshheading:11314680-Excitatory Amino Acid Antagonists,
pubmed-meshheading:11314680-Frontal Lobe,
pubmed-meshheading:11314680-Male,
pubmed-meshheading:11314680-Mesencephalon,
pubmed-meshheading:11314680-Mice,
pubmed-meshheading:11314680-Morpholines,
pubmed-meshheading:11314680-Motor Activity,
pubmed-meshheading:11314680-Norepinephrine,
pubmed-meshheading:11314680-Prazosin,
pubmed-meshheading:11314680-Stereotyped Behavior
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Modulation of MK-801-induced behaviour by noradrenergic agents in mice.
|
|
pubmed:affiliation |
Department of Pharmacology, National University of Ireland, Galway. andrew.harkin@nuigalway.ie
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
